Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Shares Outstanding (Diluted Average) (2016 - 2023)

Apyx Medical filings provide 14 years of Shares Outstanding (Diluted Average) readings, the most recent being $34.6 million for Q4 2023.

  • On a quarterly basis, Shares Outstanding (Diluted Average) changed 0.31% to $34.6 million in Q4 2023 year-over-year; TTM through Dec 2023 was $34.6 million, a 0.31% change, with the full-year FY2023 number at $34.6 million, changed 0.31% from a year prior.
  • Shares Outstanding (Diluted Average) hit $34.6 million in Q4 2023 for Apyx Medical, roughly flat from $34.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $34.6 million in Q4 2023 to a low of $34.1 million in Q4 2019.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $34.3 million (2021), compared with a mean of $34.4 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): dropped 0.86% in 2019 and later increased 0.54% in 2022.
  • Apyx Medical's Shares Outstanding (Diluted Average) stood at $34.1 million in 2019, then rose by 0.42% to $34.2 million in 2020, then increased by 0.35% to $34.3 million in 2021, then grew by 0.54% to $34.5 million in 2022, then increased by 0.31% to $34.6 million in 2023.
  • The last three reported values for Shares Outstanding (Diluted Average) were $34.6 million (Q4 2023), $34.5 million (Q4 2022), and $34.3 million (Q4 2021) per Business Quant data.